Comprehensive Pulmonary Safety Review of Inhaled Technosphere(®) Insulin in Patients with Diabetes Mellitus

BACKGROUND AND OBJECTIVE: Technosphere(®) Insulin (TI), a human insulin powder for inhalation (Afrezza(®); MannKind Corporation, Westlake Village, CA, USA), is an ultra-rapid-acting inhaled insulin indicated to improve postprandial glycemic control in patients with type 1 or type 2 diabetes mellitus...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Clin Drug Investig
Autors principals: McGill, Janet B., Peters, Anne, Buse, John B., Steiner, Susanne, Tran, Tiffany, Pompilio, Frank M., Kendall, David M.
Format: Artigo
Idioma:Inglês
Publicat: Springer International Publishing 2020
Matèries:
Original Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7511468/
https://ncbi.nlm.nih.gov/pubmed/32720187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40261-020-00958-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars